CTI BioPharma competitors

CTI BioPharma Competitors include Immunicum , AdoRx Therapeutics, Genoa Pharmaceuticals and Global Blood Therapeutics.
Add company...
CTI BioPharma
CTI BioPharma
CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers.
Immunicum
Immunicum
Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.
AdoRx Therapeutics
AdoRx Therapeutics
AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.
Genoa Pharmaceuticals
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Global Blood Therapeutics
Global Blood Therapeutics
Global Blood Therapeutics (GBT) is dedicated to discovering, developing, and commercializing novel therapeutics to transform the treatment of patients with grievous blood-based disorders.
Founding Date
Founding Date
1992
Founding Date
2002
Founding Date
N/A
Founding Date
2011
Founding Date
2012
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Göteborg, SE HQ
Locations
Edinburgh, GB HQ
Locations
Seattle, US HQ
Locations
South San Francisco, US HQ
Employees
Employees
100
Employees
137% decrease
Employees
N/A
Employees
4
Employees
9573% increase
Valuation ($)
Valuation ($)
72.2 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
2.2 b

Financial

Net income
Net income
($45m) (FY, 2017)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($117m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 10m (6 months ago)
Latest funding round
$ 62m (over 1 year ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 85.1m
Total funding raised
N/A
Total funding raised
$ 10m
Total funding raised
$ 64.2m
Total funding raised
$ 88.7m
For sources of this data, please see the company profileDownload Excel

View company profiles

Immunicum
HQ
Göteborg, SE
Employees
13↓ 7% decrease

Immunicum is a biopharmaceutical company that develops immune therapies against a range of various tumors.

View company
AdoRx Therapeutics
HQ
Edinburgh, GB

AdoRx Therapeutics is a company that pursues the discovery of new therapeutics for cancer based on modulation of the adenosine pathway.

View company
Genoa Pharmaceuticals
HQ
Seattle, US
Employees
4

Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.

View company
Global Blood Therapeutics
HQ
South San Francisco, US
Employees
95

Global Blood Therapeutics (GBT) is dedicated to discovering, developing, and commercializing novel therapeutics to transform the treatment of patients with grievous blood-based disorders.

View company